Life Sciences Real Estate Specialists | Avison Young US - United States
Trusted life sciences real estate that serves your industry's needs
Life sciences real estate services: sequencing your real estate needs
Life sciences real estate requirements are technically complex, capital intensive, and atypical for real estate service providers whose primary focus is office or warehouse space. Time-to-market and funding are crucial factors in driving innovation and successful new pharmaceutical product launches, which, in turn, require laboratories, vivaria, pilot plants, and manufacturing facilities. Our life sciences real estate specialists understand the pharmaceutical product life cycle as well as the technical complexities that can create significant budgetary and scheduling risks. We’ve successfully addressed the risks that surround life sciences real estate decision-making throughout all phases of the product life cycle and across all technical aspects of planning, designing, engineering, and constructing any type of life science space.
The centerpiece of our approach is how we integrate your technical and financial requirements into the life sciences real estate negotiation process, ensuring these requirements are incorporated accurately into the transaction documents. This fully integrated process enables our team to develop innovative strategies with credible budgets and schedules at early transaction stages, providing clients with the facts needed to make more fully informed decisions.
This transparent, risk averse, “cradle-to-grave” model creates seamless continuity and allows complete flexibility, maximizing the efficacy of our client’s internal resources on either a portfolio or transactional basis.
Life sciences real estate services include:
Strategic Real Estate Planning
Pre-Lease Budgeting and Scheduling
Site Evaluation Due Diligence Oversight
Consultant Team Selection, Engagement and Oversight
Post-Lease Project Management
U.S. life sciences market Q4 2023 insights
Despite the current surplus of lab/R&D supply across the country in the form of sublease space and new development, capital and labor markets show a healthy life science sector with a variety of indicators suggesting leasing activity will pick back up within the next 12-18 months.
The life science market experienced a significant boom amid the pandemic, but the terrain has swiftly evolved. The diminished appetite for high-risk life science research and development has led to a significant decrease of funding for the life science industry. It is crucial for both owners and occupiers to stay light on their feet to navigate and capitalize on today's rapidly changing environment.
Driven by an aging population, steady funding sources, and an urgent need to discover and develop vaccines and treatments for COVID-19, growth in life sciences industries shows no sign of slowing down. Unique location and space use requirements have made the sector resilient, drawing the attention of real estate investors in need of the services of life science commercial real estate specialists.